Our board sets out our strategic priorities and policies.
It has 2 sub-committees:
- audit and risk committee
- remuneration committee.
Sharmila Nebhrajani OBE, chairman
Sharmila read medicine at the University of Oxford, graduating with first class honours in physiological sciences. Rather than pursuing further clinical studies, she began an international business career in telecoms and technology. After the collapse of communism, she was involved in corporate restructuring across Central Europe. Sharmila was a chief operating officer for 12 years at BBC Future Media, the division that built the iPlayer.
She has significant health and science experience. From her board positions with the Medical Research Council, the Association of Medical Research Charities, as deputy chairman of the Human Fertilisation and Embryology Authority and as the chairman of the Human Tissue Authority.
She was most recently chief executive of Wilton Park, a not-for-profit agency of the Foreign and Commonwealth Office. Bringing together international policy dialogues on key issues including global health, regional and national security, climate change and artificial intelligence (AI). She sits on a range of UK boards including Severn Trent PLC, National Savings and Investments and the Health Foundation. She was also a World Fellow at the University of Yale.
Sharmila was made an OBE in 2014 for services to medical research.
Tim Irish, vice chair
Tim has worked in the life sciences industry for 30 years. His career has spanned global health technology companies across Europe and North America, including GSK, GE and Philips. Between 2007 and 2015 he served on 10 boards, 5 as chair, where he successfully executed 2 trade sales and raised significant equity financing, including an initial public offering.
His current governance portfolio covers life sciences and healthcare, both public and private, including his board role here at NICE, various European medtech supervisory board roles, and professor of practice at King’s College London’s School of Management and Business.
Elaine Inglesby-Burke DBE
Elaine has been a registered nurse since 1980. Her previous roles include being a nurse specialist manager at St Helens and Knowsley Hospital Trust and director of nursing at The Walton Centre in Liverpool. She is currently chief nursing officer for the Northern Care Alliance NHS Group, which comprises Salford Royal NHS Foundation Trust and Pennine Acute NHS Trust. She is also a trustee for the Willowbrook Hospice in St Helens.
Elaine has also played a significant role in national health campaigns, having been a member of the Prime Minister’s Nursing and Care Quality Forum. She was also involved with the Berwick National Advisory Group on the Safety of Patients in England, a group of healthcare experts that was set up to examine patient safety issues in the NHS.
Elaine was awarded a DBE for her services to nursing.
Dr Rima Makarem
Rima holds a portfolio of non-executive directorships in health and central government. She is currently external commissioner and audit chair at the House of Commons Commission and a lay member of the General Pharmaceutical Council. Her background is in the private sector, with past careers in the pharmaceutical industry and management consultancy.
Rima is chair of our audit and risk committee and is our senior independent director.
Tom Wright CBE
Dr Mark Chakravarty
Professor Gary Ford CBE, FMedSci
Gary is chief executive officer of Oxford Academic Health Science Network. He is also a consultant stroke physician at Oxford University Hospitals NHS Foundation Trust, and professor of stroke medicine at Oxford University. He is the current chair of 15 Academic HealthProfessor Gary Ford CBE Science Networks across England.
He has been part of many service innovations in UK stroke care in the last 20 years. This includes developing the first thrombolysis protocol for acute stroke in England and the Face Arm Speech Test.
Gary was director of the National Institute for Health Research (NIHR) stroke research network from 2005 to 2014. He was awarded a CBE in 2013 for services to research in stroke medicine. He is a member of the NIHR strategy board. In 2018, Gary was identified as one of 7 NIHR research legends whose work has transformed care in the NHS.
Sir Bruce Keogh
Sir Bruce has had a distinguished international career as a cardiac surgeon. He held the chair of cardiac surgery at University College London before being appointed medical director of the NHS and director general in the Department of Health. From this he moved to becoming the national medical director of NHS England.
For a decade, Sir Bruce was the professional lead for doctors in the NHS. He was responsible for clinical policy and strategy, clinical leadership, and innovation across the service. In the Department of Health, he was the sponsor for NICE, the Healthcare Commission, and the National Patient Safety Agency.
Between 2002 and 2007, Sir Bruce served on the boards of the Commission for Health Improvement and the Healthcare Commission. He is currently chair of the Birmingham Women's and Children’s NHS Foundation Trust. He was knighted for services to medicine in 2003.
Alina has had a long career in publishing and information within the private sector, including 16 years at Thomson Reuters. Her leadership has focused on the digital transformation of information for professional markets, including health. She was previously the managing director of the publishing arm of the Royal Pharmaceutical Society, which publishes a wide range of digital medicines information, including the British National Formulary (BNF).
Today, Alina holds a portfolio of board and advisory positions across several professional and academic bodies. These include the Institute of Engineering and Technology, the Royal Society of Chemistry and Manchester University Press.
Dr Justin Whatling
Dr Justin Whatling is a medical doctor with 20 years’ experience in using technology and informatics to transform outcomes for patients. He leads the population health management for Cerner outside of the US and sits on their international cabinet and product council. Prior to his role in Cerner, he was clinical director for the health sector in British Telecommunications. Justin held previous roles in Accenture and ran a health outcomes business on behalf of Bupa.
He is a founding fellow and member of the finance and audit committee and recent council member of the UK Faculty of Clinical Informatics. He is a fellow of the British Computer Society (BSC) and a member of their Academy of Computing board. He represents them on the management committee of the BMJ Health and Care Informatics journal and is a past chair for BSC Health. He also founded the Federation of Informatics Professionals.
Justin is a visiting professor in health informatics at University College London. He was previously an independent member of the NHS’s National Information Board, who set the strategy and direction for the health and care system in England on technology and information.
He has also completed 3 terms of office as a non-executive director of the BMJ publishing group. He has sat on the healthcare strategic advisory team of the Engineering and Physical Sciences Research Council.
Professor Gillian Leng CBE, chief executive
Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation
Dr Paul Chrisp, director of the Centre for Guidelines
Jennifer Howells, director of finance, strategy and transformation
Alexia Tonnel, director of digital, information and technology
The following are not voting members of the board; along with the executive directors, they make up our executive team.